Intracranial haemorrhage in children and adolescents with severe haemophilia A or B – the impact of prophylactic treatment

Nadine G. Andersson, Günter Auerswald, Chris Barnes, Manuel Carcao, Amy L. Dunn, Karin Fijnvandraat, Marianne Hoffmann, Kaan Kavakli, Gili Kenet, Rainer Kobelt, Karin Kurnik, Ri Liesner, Anne Mäkipernaa, Marilyn J. Manco-Johnson, Maria E. Mancuso, Angelo C. Molinari, Beatrice Nolan, Rosario Perez Garrido, Pia Petrini, Helen E. PlatokoukiAmy D. Shapiro, Runhui Wu, Rolf Ljung

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The discussion of prophylactic therapy in haemophilia is largely focused on joint outcomes. The impact of prophylactic therapy on intracranial haemorrhage (ICH) is less known. This study aimed to analyse ICH in children with haemophilia, with a focus on different prophylaxis regimens and sequelae of ICH. We conducted a multicentre retrospective and prospective study that included 33 haemophilia centres from 20 countries. Inclusion criteria were children and adolescents born between 1993 and 2014, with severe haemophilia A or B without inhibitors. Participants were categorized by prophylaxis regimen: full, partial or none, based on dose and dose frequency of regular infusions. The cohort study included 1515 children: 29 cases of ICH over 8038 patient years were reported. The incidence of ICH in the prophylaxis group, 0·00033 cases of ICH/patient year, was significantly lower compared to the no prophylaxis group, 0·017 cases of ICH/patient year (RR 50·06; P < 0·001) and the partial prophylaxis group, 0·0050 cases of ICH/patient year (RR 14·92; P = 0·007). In the on-demand-group, 8% (2/24) children with ICH died and 33% had long-term sequelae, including intellectual and behavioural problems, paresis and epilepsy. Children on regular, frequent prophylaxis have a low risk of ICH compared to those using non-frequent or no prophylaxis.

Original languageEnglish
Pages (from-to)298-307
Number of pages10
JournalBritish Journal of Haematology
Volume179
Issue number2
DOIs
Publication statusPublished - Oct 1 2017

Fingerprint

Hemophilia B
Intracranial Hemorrhages
Hemophilia A
Therapeutics
Paresis
Multicenter Studies
Epilepsy
Cohort Studies
Retrospective Studies
Prospective Studies

Keywords

  • children
  • factor IX
  • factor VIII
  • haemophilia A
  • haemophilia B

ASJC Scopus subject areas

  • Hematology

Cite this

Andersson, N. G., Auerswald, G., Barnes, C., Carcao, M., Dunn, A. L., Fijnvandraat, K., ... Ljung, R. (2017). Intracranial haemorrhage in children and adolescents with severe haemophilia A or B – the impact of prophylactic treatment. British Journal of Haematology, 179(2), 298-307. https://doi.org/10.1111/bjh.14844

Intracranial haemorrhage in children and adolescents with severe haemophilia A or B – the impact of prophylactic treatment. / Andersson, Nadine G.; Auerswald, Günter; Barnes, Chris; Carcao, Manuel; Dunn, Amy L.; Fijnvandraat, Karin; Hoffmann, Marianne; Kavakli, Kaan; Kenet, Gili; Kobelt, Rainer; Kurnik, Karin; Liesner, Ri; Mäkipernaa, Anne; Manco-Johnson, Marilyn J.; Mancuso, Maria E.; Molinari, Angelo C.; Nolan, Beatrice; Perez Garrido, Rosario; Petrini, Pia; Platokouki, Helen E.; Shapiro, Amy D.; Wu, Runhui; Ljung, Rolf.

In: British Journal of Haematology, Vol. 179, No. 2, 01.10.2017, p. 298-307.

Research output: Contribution to journalArticle

Andersson, NG, Auerswald, G, Barnes, C, Carcao, M, Dunn, AL, Fijnvandraat, K, Hoffmann, M, Kavakli, K, Kenet, G, Kobelt, R, Kurnik, K, Liesner, R, Mäkipernaa, A, Manco-Johnson, MJ, Mancuso, ME, Molinari, AC, Nolan, B, Perez Garrido, R, Petrini, P, Platokouki, HE, Shapiro, AD, Wu, R & Ljung, R 2017, 'Intracranial haemorrhage in children and adolescents with severe haemophilia A or B – the impact of prophylactic treatment', British Journal of Haematology, vol. 179, no. 2, pp. 298-307. https://doi.org/10.1111/bjh.14844
Andersson, Nadine G. ; Auerswald, Günter ; Barnes, Chris ; Carcao, Manuel ; Dunn, Amy L. ; Fijnvandraat, Karin ; Hoffmann, Marianne ; Kavakli, Kaan ; Kenet, Gili ; Kobelt, Rainer ; Kurnik, Karin ; Liesner, Ri ; Mäkipernaa, Anne ; Manco-Johnson, Marilyn J. ; Mancuso, Maria E. ; Molinari, Angelo C. ; Nolan, Beatrice ; Perez Garrido, Rosario ; Petrini, Pia ; Platokouki, Helen E. ; Shapiro, Amy D. ; Wu, Runhui ; Ljung, Rolf. / Intracranial haemorrhage in children and adolescents with severe haemophilia A or B – the impact of prophylactic treatment. In: British Journal of Haematology. 2017 ; Vol. 179, No. 2. pp. 298-307.
@article{11a61477ecfe476f8eeee95933e0f781,
title = "Intracranial haemorrhage in children and adolescents with severe haemophilia A or B – the impact of prophylactic treatment",
abstract = "The discussion of prophylactic therapy in haemophilia is largely focused on joint outcomes. The impact of prophylactic therapy on intracranial haemorrhage (ICH) is less known. This study aimed to analyse ICH in children with haemophilia, with a focus on different prophylaxis regimens and sequelae of ICH. We conducted a multicentre retrospective and prospective study that included 33 haemophilia centres from 20 countries. Inclusion criteria were children and adolescents born between 1993 and 2014, with severe haemophilia A or B without inhibitors. Participants were categorized by prophylaxis regimen: full, partial or none, based on dose and dose frequency of regular infusions. The cohort study included 1515 children: 29 cases of ICH over 8038 patient years were reported. The incidence of ICH in the prophylaxis group, 0·00033 cases of ICH/patient year, was significantly lower compared to the no prophylaxis group, 0·017 cases of ICH/patient year (RR 50·06; P < 0·001) and the partial prophylaxis group, 0·0050 cases of ICH/patient year (RR 14·92; P = 0·007). In the on-demand-group, 8{\%} (2/24) children with ICH died and 33{\%} had long-term sequelae, including intellectual and behavioural problems, paresis and epilepsy. Children on regular, frequent prophylaxis have a low risk of ICH compared to those using non-frequent or no prophylaxis.",
keywords = "children, factor IX, factor VIII, haemophilia A, haemophilia B",
author = "Andersson, {Nadine G.} and G{\"u}nter Auerswald and Chris Barnes and Manuel Carcao and Dunn, {Amy L.} and Karin Fijnvandraat and Marianne Hoffmann and Kaan Kavakli and Gili Kenet and Rainer Kobelt and Karin Kurnik and Ri Liesner and Anne M{\"a}kipernaa and Manco-Johnson, {Marilyn J.} and Mancuso, {Maria E.} and Molinari, {Angelo C.} and Beatrice Nolan and {Perez Garrido}, Rosario and Pia Petrini and Platokouki, {Helen E.} and Shapiro, {Amy D.} and Runhui Wu and Rolf Ljung",
year = "2017",
month = "10",
day = "1",
doi = "10.1111/bjh.14844",
language = "English",
volume = "179",
pages = "298--307",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "John Wiley & Sons, Ltd (10.1111)",
number = "2",

}

TY - JOUR

T1 - Intracranial haemorrhage in children and adolescents with severe haemophilia A or B – the impact of prophylactic treatment

AU - Andersson, Nadine G.

AU - Auerswald, Günter

AU - Barnes, Chris

AU - Carcao, Manuel

AU - Dunn, Amy L.

AU - Fijnvandraat, Karin

AU - Hoffmann, Marianne

AU - Kavakli, Kaan

AU - Kenet, Gili

AU - Kobelt, Rainer

AU - Kurnik, Karin

AU - Liesner, Ri

AU - Mäkipernaa, Anne

AU - Manco-Johnson, Marilyn J.

AU - Mancuso, Maria E.

AU - Molinari, Angelo C.

AU - Nolan, Beatrice

AU - Perez Garrido, Rosario

AU - Petrini, Pia

AU - Platokouki, Helen E.

AU - Shapiro, Amy D.

AU - Wu, Runhui

AU - Ljung, Rolf

PY - 2017/10/1

Y1 - 2017/10/1

N2 - The discussion of prophylactic therapy in haemophilia is largely focused on joint outcomes. The impact of prophylactic therapy on intracranial haemorrhage (ICH) is less known. This study aimed to analyse ICH in children with haemophilia, with a focus on different prophylaxis regimens and sequelae of ICH. We conducted a multicentre retrospective and prospective study that included 33 haemophilia centres from 20 countries. Inclusion criteria were children and adolescents born between 1993 and 2014, with severe haemophilia A or B without inhibitors. Participants were categorized by prophylaxis regimen: full, partial or none, based on dose and dose frequency of regular infusions. The cohort study included 1515 children: 29 cases of ICH over 8038 patient years were reported. The incidence of ICH in the prophylaxis group, 0·00033 cases of ICH/patient year, was significantly lower compared to the no prophylaxis group, 0·017 cases of ICH/patient year (RR 50·06; P < 0·001) and the partial prophylaxis group, 0·0050 cases of ICH/patient year (RR 14·92; P = 0·007). In the on-demand-group, 8% (2/24) children with ICH died and 33% had long-term sequelae, including intellectual and behavioural problems, paresis and epilepsy. Children on regular, frequent prophylaxis have a low risk of ICH compared to those using non-frequent or no prophylaxis.

AB - The discussion of prophylactic therapy in haemophilia is largely focused on joint outcomes. The impact of prophylactic therapy on intracranial haemorrhage (ICH) is less known. This study aimed to analyse ICH in children with haemophilia, with a focus on different prophylaxis regimens and sequelae of ICH. We conducted a multicentre retrospective and prospective study that included 33 haemophilia centres from 20 countries. Inclusion criteria were children and adolescents born between 1993 and 2014, with severe haemophilia A or B without inhibitors. Participants were categorized by prophylaxis regimen: full, partial or none, based on dose and dose frequency of regular infusions. The cohort study included 1515 children: 29 cases of ICH over 8038 patient years were reported. The incidence of ICH in the prophylaxis group, 0·00033 cases of ICH/patient year, was significantly lower compared to the no prophylaxis group, 0·017 cases of ICH/patient year (RR 50·06; P < 0·001) and the partial prophylaxis group, 0·0050 cases of ICH/patient year (RR 14·92; P = 0·007). In the on-demand-group, 8% (2/24) children with ICH died and 33% had long-term sequelae, including intellectual and behavioural problems, paresis and epilepsy. Children on regular, frequent prophylaxis have a low risk of ICH compared to those using non-frequent or no prophylaxis.

KW - children

KW - factor IX

KW - factor VIII

KW - haemophilia A

KW - haemophilia B

UR - http://www.scopus.com/inward/record.url?scp=85023170005&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85023170005&partnerID=8YFLogxK

U2 - 10.1111/bjh.14844

DO - 10.1111/bjh.14844

M3 - Article

AN - SCOPUS:85023170005

VL - 179

SP - 298

EP - 307

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 2

ER -